The role of the alcohol dehydrogenase-1 (ADH1) gene in the pathomechanism of uterine leiomyoma

Éva Csatlós, J. Rigó, Marcella Laky, Réka Brubel, Gábor József Joó

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To describe alterations of gene expression patterns of the alcohol dehydrogenase-1 (ADH1) gene in human leiomyoma tissue. We correlated changes in ADH1 gene activity with several clinical and demographic variables. Study design: We compared gene expression patterns of ADH1 in leiomyoma tissue samples obtained from 101 hysterectomy cases to 110 cases of hysterectomy performed for non-oncological indications. Gene expression was determined by standard PCR technique. Clinical and epidemiological data were extracted from the computerized database of the 1st Department of Obstetrics and Gynecology of Semmelweis University and from patient questionnaires. Results Median age in the leiomyoma group was significantly lower than in the control group (47.5 ± 12.1 vs. 54.7 ± 10.2 years). The incidence of uterine leiomyoma was highest (48%) in the 41-50 year age group. In the obstetric history, cumulative gestational age in the leiomyoma group was significantly lower (105.1 ± 8.2 weeks) than in the control group (127.2 ± 9.1 weeks) and cumulative lactation length was also significantly shorter (2.4 ± 1.2 months vs. 5.1 ± 2.2 months). Surgical treatment of the fibroid was myomectomy in 39.6% of the cases and hysterectomy in 60.4%. The ADH1 gene was significantly underexpressed in the leiomyoma group compared to the control group. There was no significant association between ADH1 gene expression and family history. Within the leiomyoma group, there was no significant difference in ADH1 gene expression between subgroups of cases with different number of fibroid tumors found in the hysterectomy sample, but individual tumor number did correlate with the degree of underexpression of the ADH1 gene. There was no significant association between ADH1 gene expression and cumulative history of lactation. Conclusions: Underexpression of the ADH1 gene, which influences the transformation of the extracellular matrix, plays a probable role in the etiology of uterine fibroid. Although significant differences in ADH1 gene activity were not seen, a negative correlation between tumor number and degree of ADH1 underexpression was found. Neither family history nor cumulative lactation length was a significant predictor of uterine leiomyoma.

Original languageEnglish
Pages (from-to)492-496
Number of pages5
JournalEuropean Journal of Obstetrics Gynecology and Reproductive Biology
Volume170
Issue number2
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Alcohol Dehydrogenase
Leiomyoma
Genes
Hysterectomy
Gene Expression
Lactation
Control Groups
Uterine Myomectomy
Hospital Obstetrics and Gynecology Department
Gynecology
Gestational Age
Obstetrics
Extracellular Matrix
Neoplasms
Age Groups
History
Demography
Databases

Keywords

  • ADH1 gene
  • Extracellular matrix
  • Retinol metabolism
  • Uterine fibroid
  • Uterine leiomyoma

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

The role of the alcohol dehydrogenase-1 (ADH1) gene in the pathomechanism of uterine leiomyoma. / Csatlós, Éva; Rigó, J.; Laky, Marcella; Brubel, Réka; Joó, Gábor József.

In: European Journal of Obstetrics Gynecology and Reproductive Biology, Vol. 170, No. 2, 10.2013, p. 492-496.

Research output: Contribution to journalArticle

Csatlós, Éva ; Rigó, J. ; Laky, Marcella ; Brubel, Réka ; Joó, Gábor József. / The role of the alcohol dehydrogenase-1 (ADH1) gene in the pathomechanism of uterine leiomyoma. In: European Journal of Obstetrics Gynecology and Reproductive Biology. 2013 ; Vol. 170, No. 2. pp. 492-496.
@article{6b1a4fe7f6a94d0bb364131013427cd4,
title = "The role of the alcohol dehydrogenase-1 (ADH1) gene in the pathomechanism of uterine leiomyoma",
abstract = "Objective: To describe alterations of gene expression patterns of the alcohol dehydrogenase-1 (ADH1) gene in human leiomyoma tissue. We correlated changes in ADH1 gene activity with several clinical and demographic variables. Study design: We compared gene expression patterns of ADH1 in leiomyoma tissue samples obtained from 101 hysterectomy cases to 110 cases of hysterectomy performed for non-oncological indications. Gene expression was determined by standard PCR technique. Clinical and epidemiological data were extracted from the computerized database of the 1st Department of Obstetrics and Gynecology of Semmelweis University and from patient questionnaires. Results Median age in the leiomyoma group was significantly lower than in the control group (47.5 ± 12.1 vs. 54.7 ± 10.2 years). The incidence of uterine leiomyoma was highest (48{\%}) in the 41-50 year age group. In the obstetric history, cumulative gestational age in the leiomyoma group was significantly lower (105.1 ± 8.2 weeks) than in the control group (127.2 ± 9.1 weeks) and cumulative lactation length was also significantly shorter (2.4 ± 1.2 months vs. 5.1 ± 2.2 months). Surgical treatment of the fibroid was myomectomy in 39.6{\%} of the cases and hysterectomy in 60.4{\%}. The ADH1 gene was significantly underexpressed in the leiomyoma group compared to the control group. There was no significant association between ADH1 gene expression and family history. Within the leiomyoma group, there was no significant difference in ADH1 gene expression between subgroups of cases with different number of fibroid tumors found in the hysterectomy sample, but individual tumor number did correlate with the degree of underexpression of the ADH1 gene. There was no significant association between ADH1 gene expression and cumulative history of lactation. Conclusions: Underexpression of the ADH1 gene, which influences the transformation of the extracellular matrix, plays a probable role in the etiology of uterine fibroid. Although significant differences in ADH1 gene activity were not seen, a negative correlation between tumor number and degree of ADH1 underexpression was found. Neither family history nor cumulative lactation length was a significant predictor of uterine leiomyoma.",
keywords = "ADH1 gene, Extracellular matrix, Retinol metabolism, Uterine fibroid, Uterine leiomyoma",
author = "{\'E}va Csatl{\'o}s and J. Rig{\'o} and Marcella Laky and R{\'e}ka Brubel and Jo{\'o}, {G{\'a}bor J{\'o}zsef}",
year = "2013",
month = "10",
doi = "10.1016/j.ejogrb.2013.07.007",
language = "English",
volume = "170",
pages = "492--496",
journal = "European Journal of Obstetrics and Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - The role of the alcohol dehydrogenase-1 (ADH1) gene in the pathomechanism of uterine leiomyoma

AU - Csatlós, Éva

AU - Rigó, J.

AU - Laky, Marcella

AU - Brubel, Réka

AU - Joó, Gábor József

PY - 2013/10

Y1 - 2013/10

N2 - Objective: To describe alterations of gene expression patterns of the alcohol dehydrogenase-1 (ADH1) gene in human leiomyoma tissue. We correlated changes in ADH1 gene activity with several clinical and demographic variables. Study design: We compared gene expression patterns of ADH1 in leiomyoma tissue samples obtained from 101 hysterectomy cases to 110 cases of hysterectomy performed for non-oncological indications. Gene expression was determined by standard PCR technique. Clinical and epidemiological data were extracted from the computerized database of the 1st Department of Obstetrics and Gynecology of Semmelweis University and from patient questionnaires. Results Median age in the leiomyoma group was significantly lower than in the control group (47.5 ± 12.1 vs. 54.7 ± 10.2 years). The incidence of uterine leiomyoma was highest (48%) in the 41-50 year age group. In the obstetric history, cumulative gestational age in the leiomyoma group was significantly lower (105.1 ± 8.2 weeks) than in the control group (127.2 ± 9.1 weeks) and cumulative lactation length was also significantly shorter (2.4 ± 1.2 months vs. 5.1 ± 2.2 months). Surgical treatment of the fibroid was myomectomy in 39.6% of the cases and hysterectomy in 60.4%. The ADH1 gene was significantly underexpressed in the leiomyoma group compared to the control group. There was no significant association between ADH1 gene expression and family history. Within the leiomyoma group, there was no significant difference in ADH1 gene expression between subgroups of cases with different number of fibroid tumors found in the hysterectomy sample, but individual tumor number did correlate with the degree of underexpression of the ADH1 gene. There was no significant association between ADH1 gene expression and cumulative history of lactation. Conclusions: Underexpression of the ADH1 gene, which influences the transformation of the extracellular matrix, plays a probable role in the etiology of uterine fibroid. Although significant differences in ADH1 gene activity were not seen, a negative correlation between tumor number and degree of ADH1 underexpression was found. Neither family history nor cumulative lactation length was a significant predictor of uterine leiomyoma.

AB - Objective: To describe alterations of gene expression patterns of the alcohol dehydrogenase-1 (ADH1) gene in human leiomyoma tissue. We correlated changes in ADH1 gene activity with several clinical and demographic variables. Study design: We compared gene expression patterns of ADH1 in leiomyoma tissue samples obtained from 101 hysterectomy cases to 110 cases of hysterectomy performed for non-oncological indications. Gene expression was determined by standard PCR technique. Clinical and epidemiological data were extracted from the computerized database of the 1st Department of Obstetrics and Gynecology of Semmelweis University and from patient questionnaires. Results Median age in the leiomyoma group was significantly lower than in the control group (47.5 ± 12.1 vs. 54.7 ± 10.2 years). The incidence of uterine leiomyoma was highest (48%) in the 41-50 year age group. In the obstetric history, cumulative gestational age in the leiomyoma group was significantly lower (105.1 ± 8.2 weeks) than in the control group (127.2 ± 9.1 weeks) and cumulative lactation length was also significantly shorter (2.4 ± 1.2 months vs. 5.1 ± 2.2 months). Surgical treatment of the fibroid was myomectomy in 39.6% of the cases and hysterectomy in 60.4%. The ADH1 gene was significantly underexpressed in the leiomyoma group compared to the control group. There was no significant association between ADH1 gene expression and family history. Within the leiomyoma group, there was no significant difference in ADH1 gene expression between subgroups of cases with different number of fibroid tumors found in the hysterectomy sample, but individual tumor number did correlate with the degree of underexpression of the ADH1 gene. There was no significant association between ADH1 gene expression and cumulative history of lactation. Conclusions: Underexpression of the ADH1 gene, which influences the transformation of the extracellular matrix, plays a probable role in the etiology of uterine fibroid. Although significant differences in ADH1 gene activity were not seen, a negative correlation between tumor number and degree of ADH1 underexpression was found. Neither family history nor cumulative lactation length was a significant predictor of uterine leiomyoma.

KW - ADH1 gene

KW - Extracellular matrix

KW - Retinol metabolism

KW - Uterine fibroid

KW - Uterine leiomyoma

UR - http://www.scopus.com/inward/record.url?scp=84885184139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885184139&partnerID=8YFLogxK

U2 - 10.1016/j.ejogrb.2013.07.007

DO - 10.1016/j.ejogrb.2013.07.007

M3 - Article

C2 - 23891545

AN - SCOPUS:84885184139

VL - 170

SP - 492

EP - 496

JO - European Journal of Obstetrics and Gynecology and Reproductive Biology

JF - European Journal of Obstetrics and Gynecology and Reproductive Biology

SN - 0028-2243

IS - 2

ER -